Viewing Study NCT03911557


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-02-25 @ 8:15 PM
Study NCT ID: NCT03911557
Status: COMPLETED
Last Update Posted: 2025-11-12
First Post: 2019-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
Sponsor: John L. Villano, MD, PhD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tumor, Solid View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mutational burden View
None TMB View
None PD-1 View
None CTLA-4 View
None MEDI4736 View
None durvalumab View
None tremelimumab View
None immune therapy View
None refractory View